Amring Pharmaceuticals, Inc.
Records under this name other than patents Amring Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Amring Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,947,739 | Tranexamic Acid Formulations Term ended Ended no later than Mar 4, 2025 · Medium confidence | Term ended | Ended no later than Mar 4, 2025 | Medium confidence |
| US 8,022,106 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,273,795 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,487,005 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,791,160 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,809,394 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,957,113 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 8,968,777 | Tranexamic acid formulations with reduced adverse effects Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |
| US 9,060,939 | Tranexamic Acid Formulations Term ended Term ended Mar 4, 2025 · Medium confidence | Term ended | Term ended Mar 4, 2025 | Medium confidence |